Skip to main content
Top
Published in: Endocrine 2/2011

01-10-2011 | Original Article

Elevated serum γ-glutamyltransferase predicts the development of impaired glucose metabolism in middle-aged and elderly Chinese

Authors: Yu Xu, Min Xu, Yun Huang, Tiange Wang, Mian Li, Yaohua Wu, Aiyun Song, Xiaoying Li, Yufang Bi, Guang Ning

Published in: Endocrine | Issue 2/2011

Login to get access

Abstract

The aim of this article is to prospectively investigate the association of the liver enzyme γ-glutamyltransferase (GGT) with the development of diabetes and impaired glucose regulation (IGR) in a Chinese population. Seven hundred and sixty normoglycaemic subjects aged 40 years or older randomly selected from an urban community of Shanghai received a baseline investigation in May 2005. The participants were invited to receive a standard 75-g oral glucose tolerance test (OGTT) in November 2008. Incident diabetes and IGR were determined according to the 1999 WHO criteria. Serum GGT levels were significantly associated with incident diabetes or combined diabetes and IGR prospectively. After extensive adjustment, the diabetes risk was significantly increased with incrementing serum GGT quartiles (P value for trend = 0.0027). As compared with the lowest quartile of GGT, the highest quartile had an adjusted hazard ratio of 1.30 (95% CI 1.03–1.65) for developing combined diabetes and IGR. Furthermore, a high serum GGT level at baseline was independently associated with an increase in the index of homeostasis model assessment of insulin resistance (HOMA-IR) at follow-up. Serum GGT concentration, even within its normal range, is a risk marker for developing impaired glucose metabolism in middle-aged and elderly Chinese.
Appendix
Available only for authorised users
Literature
1.
go back to reference G. Marchesini, M. Brizi, G. Bianchi, S. Tomassetti, E. Bugianesi, M. Lenzi, A.J. McCullough, S. Natale, G. Forlani, N. Melchionda, Diabetes 50, 1844–1850 (2001)PubMedCrossRef G. Marchesini, M. Brizi, G. Bianchi, S. Tomassetti, E. Bugianesi, M. Lenzi, A.J. McCullough, S. Natale, G. Forlani, N. Melchionda, Diabetes 50, 1844–1850 (2001)PubMedCrossRef
4.
go back to reference D.J. Kim, J.H. Noh, N.H. Cho, B.W. Lee, Y.H. Choi, J.H. Jung, Y.K. Min, M.S. Lee, M.K. Lee, K.W. Kim, Diabet. Med. 22, 1134–1140 (2005)PubMedCrossRef D.J. Kim, J.H. Noh, N.H. Cho, B.W. Lee, Y.H. Choi, J.H. Jung, Y.K. Min, M.S. Lee, M.K. Lee, K.W. Kim, Diabet. Med. 22, 1134–1140 (2005)PubMedCrossRef
7.
go back to reference Y. Doi, M. Kubo, K. Yonemoto, T. Ninomiya, M. Iwase, Y. Tanizaki, K. Shikata, M. Iida, Y. Kiyohara, Obesity Res. 15, 1841–1850 (2007)CrossRef Y. Doi, M. Kubo, K. Yonemoto, T. Ninomiya, M. Iwase, Y. Tanizaki, K. Shikata, M. Iida, Y. Kiyohara, Obesity Res. 15, 1841–1850 (2007)CrossRef
8.
go back to reference E.S. Ford, M.B. Schulze, M.M. Bergmann, C. Thamer, H.G. Joost, H. Boeing, Diabetes Care 31, 1138–1143 (2008)PubMedCrossRef E.S. Ford, M.B. Schulze, M.M. Bergmann, C. Thamer, H.G. Joost, H. Boeing, Diabetes Care 31, 1138–1143 (2008)PubMedCrossRef
9.
go back to reference A. Fraser, R. Harris, N. Sattar, S. Ebrahim, G. Davey Smith, D.A. Lawlor, Diabetes Care 32, 741–750 (2009)PubMedCrossRef A. Fraser, R. Harris, N. Sattar, S. Ebrahim, G. Davey Smith, D.A. Lawlor, Diabetes Care 32, 741–750 (2009)PubMedCrossRef
10.
go back to reference M. Nannipieri, C. Gonzales, S. Baldi, R. Posadas, K. Williams, S.M. Haffner, M.P. Stern, E. Ferrannini, Diabetes Care 28, 1757–1762 (2005)PubMedCrossRef M. Nannipieri, C. Gonzales, S. Baldi, R. Posadas, K. Williams, S.M. Haffner, M.P. Stern, E. Ferrannini, Diabetes Care 28, 1757–1762 (2005)PubMedCrossRef
11.
go back to reference P. André, B. Balkau, S. Vol, M.A. Charles, E. Eschwège, DESIR Study Group, Diabetes Care 30, 2355–2361 (2007)PubMedCrossRef P. André, B. Balkau, S. Vol, M.A. Charles, E. Eschwège, DESIR Study Group, Diabetes Care 30, 2355–2361 (2007)PubMedCrossRef
12.
go back to reference D.S. Lee, J.C. Evans, S.J. Robins, P.W. Wilson, I. Albano, C.S. Fox, T.J. Wang, E.J. Benjamin, R.B. D’Agostino, R.S. Vasan, Arterioscler. Thromb. Vasc. Biol. 27, 127–133 (2007)PubMedCrossRef D.S. Lee, J.C. Evans, S.J. Robins, P.W. Wilson, I. Albano, C.S. Fox, T.J. Wang, E.J. Benjamin, R.B. D’Agostino, R.S. Vasan, Arterioscler. Thromb. Vasc. Biol. 27, 127–133 (2007)PubMedCrossRef
13.
go back to reference J. Xiang, X.Y. Li, M. Xu, J. Hong, Y. Huang, J.R. Tan, X. Lu, M. Dai, B. Yu, G. Ning, J. Clin. Endocrinol. Metab. 93, 4107–4112 (2008)PubMedCrossRef J. Xiang, X.Y. Li, M. Xu, J. Hong, Y. Huang, J.R. Tan, X. Lu, M. Dai, B. Yu, G. Ning, J. Clin. Endocrinol. Metab. 93, 4107–4112 (2008)PubMedCrossRef
14.
go back to reference M. Xu, X.Y. Li, J.G. Wang, X.J. Wang, Y. Huang, Q. Cheng, H.E. Huang, R. Li, J. Xiang, J.R. Tan, M. Dai, G. Ning, Diabetologia 52, 1511–1519 (2009)PubMedCrossRef M. Xu, X.Y. Li, J.G. Wang, X.J. Wang, Y. Huang, Q. Cheng, H.E. Huang, R. Li, J. Xiang, J.R. Tan, M. Dai, G. Ning, Diabetologia 52, 1511–1519 (2009)PubMedCrossRef
17.
go back to reference T.P. Whitehead, D. Robinson, S.L. Allaway, Ann. Clin. Biochem. 33, 530–535 (1996)PubMed T.P. Whitehead, D. Robinson, S.L. Allaway, Ann. Clin. Biochem. 33, 530–535 (1996)PubMed
19.
go back to reference M. Emdin, C. Passino, C. Michelassi, F. Titta, A. L’abbate, L. Donato, A. Pompella, A. Paolicchi, Eur. Heart J. 22, 1802–1807 (2001)PubMedCrossRef M. Emdin, C. Passino, C. Michelassi, F. Titta, A. L’abbate, L. Donato, A. Pompella, A. Paolicchi, Eur. Heart J. 22, 1802–1807 (2001)PubMedCrossRef
20.
21.
go back to reference E. Ruttmann, L.J. Brant, H. Concin, G. Diem, K. Rapp, H. Ulmer, Circulation 112, 2130–2137 (2005)PubMedCrossRef E. Ruttmann, L.J. Brant, H. Concin, G. Diem, K. Rapp, H. Ulmer, Circulation 112, 2130–2137 (2005)PubMedCrossRef
22.
go back to reference H.J. Forman, R.M. Liu, L. Tian, Lung Biol. Health Dis. 105, 99–121 (1997) H.J. Forman, R.M. Liu, L. Tian, Lung Biol. Health Dis. 105, 99–121 (1997)
23.
go back to reference A. Paolicchi, M. Emdin, E. Ghliozeni, E. Ciancia, C. Passino, G. Popoff, A. Pompella, Circulation 109, 1440 (2004)PubMedCrossRef A. Paolicchi, M. Emdin, E. Ghliozeni, E. Ciancia, C. Passino, G. Popoff, A. Pompella, Circulation 109, 1440 (2004)PubMedCrossRef
25.
go back to reference D.H. Lee, L.M. Steffen, D.R. Jacobs, Am. J. Clin. Nutr. 79, 600–605 (2004)PubMed D.H. Lee, L.M. Steffen, D.R. Jacobs, Am. J. Clin. Nutr. 79, 600–605 (2004)PubMed
Metadata
Title
Elevated serum γ-glutamyltransferase predicts the development of impaired glucose metabolism in middle-aged and elderly Chinese
Authors
Yu Xu
Min Xu
Yun Huang
Tiange Wang
Mian Li
Yaohua Wu
Aiyun Song
Xiaoying Li
Yufang Bi
Guang Ning
Publication date
01-10-2011
Publisher
Springer US
Published in
Endocrine / Issue 2/2011
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-011-9468-z

Other articles of this Issue 2/2011

Endocrine 2/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.